Yuka Yamaguchi, MD
Urology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 1 carrier
- Offices
- 6
Offices
6 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plans that list them
13 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Yamaguchi’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A139890 · Current
Licensed to practise in California · since 2015 · expires 2027-07-31 · University of Michigan Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$193,495
Medicare paid this office $193,495 for 483 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 267 | $44,172 | $112 |
| Diagnostic exam of bladder and urethra using an endoscope | 117 | $34,175 | $246 |
| New patient visit (45+ min) | 118 | $16,703 | $142 |
| Short return visit (20+ min) | 167 | $16,463 | $78 |
| Long return visit (40+ min) | 20 | $3,297 | $165 |
See all 11 services
| Return visit (30+ min) | 267 | $44,172 | $112 |
| Diagnostic exam of bladder and urethra using an endoscope | 117 | $34,175 | $246 |
| New patient visit (45+ min) | 118 | $16,703 | $142 |
| Short return visit (20+ min) | 167 | $16,463 | $78 |
| Long return visit (40+ min) | 20 | $3,297 | $165 |
| New patient visit (30+ min) | 27 | $2,790 | $103 |
| Biopsy of prostate gland | 11 | $2,652 | $241 |
| Ultrasound scan of pelvic region through rectum | 13 | $1,864 | $143 |
| Ultrasound measurement of bladder capacity after voiding | 114 | $1,496 | $11 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 57 | $928 | $15 |
| Automated urinalysis test | 169 | $458 | $2 |
Procedures Medicare counted
| Prostate resection | 1-10 | None |
| Removal of skin lesions | 1-10 | None |
Who their Medicare patients are
483 Original Medicare patients in 2024. Average age 77 · Women 39% · Also on Medicaid 6% · Health risk score 0.91. At or below the middle of the specialty; the typical urology clinician is at 1.36.
Conditions among them: High blood pressure 67% · Coronary heart disease 29% · Cancer 23% · Atrial fibrillation 18% · Chronic kidney disease 17% · Diabetes 16% · Depression 13% · Heart failure 11% · COPD 6% · Dementia 4% · Stroke 4%.
The office billed $827,223, Medicare allowed $255,070 and paid $193,495; for 2,123 services of 77 kinds; $20,728 of it was for drugs given in the office and $172,768 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 483 | 2,123 | 77 | 0.91 | $827,223 | $193,495 |
| 2023 | 410 | 2,015 | 76 | 1.02 | $624,670 | $151,305 |
| 2022 | 585 | 5,398 | 77 | 1.02 | $1,015,546 | $262,669 |
| 2021 | 524 | 5,033 | 77 | 1.07 | $834,372 | $206,791 |
| 2020 | 495 | 4,883 | 77 | 1.23 | $716,765 | $165,817 |
| 2019 | 338 | 2,773 | 77 | 1.25 | $448,335 | $107,398 |
| 2018 | 157 | 280 | 70 | 1.77 | $161,744 | $17,643 |
| 2017 | 156 | 414 | 68 | 1.78 | $163,122 | $32,594 |
| 2016 | 141 | 373 | 67 | 1.55 | $131,902 | $33,624 |
| 2015 | 27 | 63 | 69 | 2.10 | $41,733 | $5,071 |
| 2014 | 17 | 28 | 78 | 1.55 | $14,770 | $2,245 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Return visit (30+ min) | 242 | $35,549 | $110 |
| Diagnostic exam of bladder and urethra using an endoscope | 77 | $21,419 | $246 |
| New patient visit (45+ min) | 88 | $11,494 | $131 |
| Short return visit (20+ min) | 109 | $9,708 | $78 |
| Insertion of lower leg neurostimulator electrode | 13 | $4,348 | $111 |
| Long return visit (40+ min) | 17 | $3,300 | $174 |
| New patient visit (30+ min) | 16 | $1,572 | $98 |
| Ultrasound measurement of bladder capacity after voiding | 127 | $1,485 | $11 |
| Ultrasound scan of pelvic region through rectum | 11 | $1,461 | $133 |
| Automated urinalysis test | 136 | $348 | $2 |
| Injection of drug or substance under skin or into muscle | 13 | $257 | $14 |
| Injection, garamycin, gentamicin, up to 80 mg | 12 | $38 | None |
2022: 16 services
| Return visit (30+ min) | 299 | $54,179 | $116 |
| New patient visit (45+ min) | 214 | $30,176 | $141 |
| Diagnostic exam of bladder and urethra using an endoscope | 106 | $29,190 | $252 |
| Short return visit (20+ min) | 150 | $15,685 | $83 |
| Insertion of lower leg neurostimulator electrode | 28 | $12,639 | $125 |
| Complicated insertion of bladder tube | 13 | $5,562 | $150 |
| Simple insertion of temporary bladder tube | 16 | $4,815 | $60 |
| Long return visit (40+ min) | 17 | $3,305 | $174 |
| Biopsy of prostate gland | 12 | $3,001 | $250 |
| Ultrasound measurement of bladder capacity after voiding | 200 | $2,374 | $10 |
| New patient visit (30+ min) | 23 | $2,014 | $88 |
| Ultrasound scan of pelvic region through rectum | 16 | $1,284 | $80 |
| Automated urinalysis test | 203 | $559 | $2 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 18 | $385 | $21 |
| Injection of drug or substance under skin or into muscle | 15 | $261 | $14 |
| Injection, garamycin, gentamicin, up to 80 mg | 13 | $35 | None |
2021: 16 services
| Return visit (30+ min) | 232 | $39,370 | $116 |
| Diagnostic exam of bladder and urethra using an endoscope | 106 | $29,391 | $239 |
| New patient visit (45+ min) | 182 | $27,458 | $151 |
| Short return visit (20+ min) | 176 | $18,906 | $81 |
| Insertion of lower leg neurostimulator electrode | 27 | $11,419 | $131 |
| Simple insertion of temporary bladder tube | 26 | $7,878 | $64 |
| Complicated insertion of bladder tube | 17 | $4,471 | $149 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 12 | $4,249 | $354 |
| Long return visit (40+ min) | 21 | $4,008 | $174 |
| New patient visit (30+ min) | 32 | $3,237 | $101 |
| Ultrasound measurement of bladder capacity after voiding | 190 | $2,519 | $11 |
| Telephone medical discussion with physician, 21-30 minutes | 16 | $1,614 | $95 |
| Automated urinalysis test | 217 | $605 | $2 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 16 | $388 | $23 |
| Injection of drug or substance under skin or into muscle | 14 | $285 | $14 |
| Electronic assessment of bladder emptying | 11 | $158 | $11 |
2020: 17 services
| Diagnostic exam of bladder and urethra using an endoscope | 104 | $28,178 | $212 |
| Return visit (30+ min) | 136 | $17,688 | $99 |
| Short return visit (20+ min) | 193 | $17,439 | $65 |
| New patient visit (30+ min) | 141 | $13,188 | $94 |
| New patient visit (45+ min) | 89 | $12,405 | $139 |
| Insertion of lower leg neurostimulator electrode | 22 | $6,855 | $129 |
| Simple insertion of temporary bladder tube | 24 | $6,422 | $59 |
| Biopsy of prostate gland | 16 | $3,896 | $243 |
| Telephone medical discussion with physician, 21-30 minutes | 24 | $2,578 | $103 |
| Long return visit (40+ min) | 16 | $2,271 | $142 |
| Telephone medical discussion with physician, 11-20 minutes | 21 | $1,535 | $70 |
| Ultrasound measurement of bladder capacity after voiding | 124 | $1,421 | $10 |
| Simple bladder irrigation and/or instillation | 12 | $1,226 | $72 |
| Short return visit | 23 | $1,002 | $42 |
| Automated urinalysis test | 212 | $602 | $2 |
| Injection of drug or substance under skin or into muscle | 24 | $526 | $13 |
| Injection, garamycin, gentamicin, up to 80 mg | 17 | $57 | None |
2019: 11 services
| Diagnostic exam of bladder and urethra using an endoscope | 74 | $15,457 | $186 |
| Short return visit (20+ min) | 144 | $13,653 | $70 |
| New patient visit (30+ min) | 102 | $9,949 | $98 |
| New patient visit (45+ min) | 45 | $6,581 | $146 |
| Insertion of lower leg neurostimulator electrode | 20 | $5,761 | $131 |
| Return visit (30+ min) | 50 | $5,212 | $100 |
| Ultrasound measurement of bladder capacity after voiding | 91 | $1,594 | $13 |
| Simple insertion of temporary bladder tube | 16 | $1,581 | $61 |
| Short return visit | 32 | $1,483 | $44 |
| Automated urinalysis test | 166 | $522 | $2 |
| Injection of drug or substance under skin or into muscle | 14 | $229 | $16 |
2018: 4 services
| Short return visit (20+ min) | 82 | $4,105 | $37 |
| Diagnostic exam of bladder and urethra using an endoscope | 20 | $1,395 | $63 |
| New patient visit (30+ min) | 18 | $1,065 | $59 |
| Short return visit | 30 | $618 | $19 |
2017: 10 services
| Short return visit (20+ min) | 52 | $3,826 | $61 |
| Return visit (30+ min) | 30 | $2,730 | $88 |
| Diagnostic exam of bladder and urethra using an endoscope | 12 | $1,761 | $126 |
| New patient visit (45+ min) | 12 | $1,527 | $127 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,202 | $63 |
| Simple bladder irrigation and/or instillation | 15 | $1,191 | $70 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 12 | $1,052 | $88 |
| Ultrasound measurement of bladder capacity after voiding | 44 | $937 | $18 |
| Short return visit | 11 | $530 | $41 |
| Urinalysis, manual test | 47 | $189 | $3 |
2016: 8 services
| Short return visit (20+ min) | 51 | $4,162 | $64 |
| Return visit (30+ min) | 30 | $3,078 | $93 |
| Diagnostic exam of bladder and urethra using an endoscope | 13 | $2,488 | $178 |
| New patient visit (45+ min) | 14 | $1,908 | $136 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 13 | $1,120 | $86 |
| Short return visit | 23 | $910 | $40 |
| Ultrasound measurement of bladder capacity after voiding | 33 | $671 | $19 |
| Urinalysis, manual test | 32 | $119 | $3 |
2015: 1 service
| Ultrasound measurement of bladder capacity after voiding | 12 | $243 | $17 |
Medicaid work
$26,026 in 2018
Medicaid paid $26,026 for 484 billed services this clinician did in 2018, up to 56 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 79 | $13,470 |
| Short return visit (20+ min) | 343 | $11,227 |
| Short return visit | 50 | $902 |
| New patient visit (30+ min) | 12 | $427 |
| 2018 | 484 | 4 | 56 | $26,026 |
Drugs they prescribed that Part D paid
$199,753
Pharmacies billed $199,753 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (19 of 1,545) in 2024. At or below the middle of the specialty; the typical urology clinician is at 2%.
1,288 generic and fewer than 11 brand-name prescriptions · $199,753 in drug cost · 232 antibiotic prescriptions to 118 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Myrbetriq | 173 | $118,344 | $684 |
| Gemtesa | 63 | $44,332 | $704 |
| Estradiol | 124 | $8,530 | $69 |
| Tamsulosin | 381 | $6,603 | $17 |
| Finasteride | 295 | $4,132 | $14 |
See all 21 drugs
| Myrbetriq | 173 | $118,344 | $684 |
| Gemtesa | 63 | $44,332 | $704 |
| Estradiol | 124 | $8,530 | $69 |
| Tamsulosin | 381 | $6,603 | $17 |
| Finasteride | 295 | $4,132 | $14 |
| Potassium Citrate Er | 23 | $3,509 | $153 |
| Solifenacin | 14 | $1,936 | $138 |
| Methenamine Hippurate | 14 | $1,722 | $123 |
| Tadalafil | 27 | $1,544 | $57 |
| Silodosin | 11 | $1,075 | $98 |
| Oxybutynin Chloride Er | 47 | $1,003 | $21 |
| Cephalexin | 62 | $518 | $8 |
| Allopurinol | 19 | $415 | $22 |
| Nitrofurantoin Mono-Macro | 25 | $381 | $15 |
| Alfuzosin Hcl Er | 34 | $376 | $11 |
| Nitrofurantoin | 20 | $304 | $15 |
| Ciprofloxacin | 40 | $207 | $5 |
| Amoxicillin-Clavulanate Potass | 14 | $186 | $13 |
| Sulfamethoxazole-Trimethoprim | 44 | $160 | $4 |
| Hydrocodone-Acetaminophen | 19 | $101 | $5 |
| Levofloxacin | 11 | $90 | $8 |
Year by year
| 2024 | 1,545 | 401 | 1% (19) | None | $199,753 |
| 2023 | 1,312 | 349 | None | 20% | $237,475 |
| 2022 | 1,595 | 386 | 2% (25) | 22% | $363,140 |
| 2021 | 1,340 | 341 | 3% (41) | None | $271,388 |
| 2020 | 1,002 | 271 | 3% (27) | None | $243,345 |
| 2019 | 374 | 148 | 4% (14) | 12% | $92,242 |
| 2018 | 121 | 51 | 9% (11) | None | $4,495 |
| 2017 | 98 | 38 | 13% (13) | None | $1,494 |
| 2016 | 115 | 38 | None | 18% | $3,541 |
| 2015 | 140 | 37 | None | 19% | $9,640 |
| 2014 | 43 | 24 | 42% (18) | None | $2,824 |
| 2013 | 145 | 80 | 42% (61) | None | $4,731 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 15 drugs
| Myrbetriq | 179 | $116,233 | $649 |
| Potassium Citrate Er | 42 | $9,203 | $219 |
| Estradiol | 82 | $7,251 | $88 |
| Tamsulosin | 306 | $5,988 | $20 |
| Finasteride | 269 | $4,810 | $18 |
| Solifenacin | 17 | $2,128 | $125 |
| Oxybutynin Chloride Er | 45 | $1,482 | $33 |
| Nitrofurantoin | 48 | $1,010 | $21 |
| Trimethoprim | 12 | $705 | $59 |
| Nitrofurantoin Mono-Macro | 23 | $474 | $21 |
| Allopurinol | 16 | $401 | $25 |
| Cephalexin | 62 | $351 | $6 |
| Tadalafil | 17 | $269 | $16 |
| Sulfamethoxazole-Trimethoprim | 42 | $161 | $4 |
| Ciprofloxacin | 19 | $82 | $4 |
2022: 19 drugs
| Xtandi | 12 | $165,844 | $13,820 |
| Myrbetriq | 267 | $147,457 | $552 |
| Potassium Citrate Er | 46 | $10,995 | $239 |
| Estradiol | 114 | $10,686 | $94 |
| Tamsulosin | 308 | $5,475 | $18 |
| Finasteride | 258 | $4,690 | $18 |
| Oxybutynin Chloride Er | 76 | $3,307 | $44 |
| Methenamine Hippurate | 25 | $3,225 | $129 |
| Cephalexin | 100 | $1,059 | $11 |
| Nitrofurantoin | 38 | $1,048 | $28 |
| Nitrofurantoin Mono-Macro | 45 | $713 | $16 |
| Trimethoprim | 18 | $608 | $34 |
| Alfuzosin Hcl Er | 17 | $353 | $21 |
| Allopurinol | 15 | $303 | $20 |
| Sulfamethoxazole-Trimethoprim | 66 | $253 | $4 |
| Ciprofloxacin | 31 | $128 | $4 |
| Hydrocodone-Acetaminophen | 17 | $99 | $6 |
| Fluconazole | 13 | $62 | $5 |
| Levofloxacin | 11 | $56 | $5 |
2021: 18 drugs
| Myrbetriq | 168 | $90,760 | $540 |
| Estradiol | 93 | $10,829 | $116 |
| Potassium Citrate Er | 41 | $7,280 | $178 |
| Tamsulosin | 279 | $5,140 | $18 |
| Finasteride | 156 | $4,062 | $26 |
| Methenamine Hippurate | 31 | $3,855 | $124 |
| Oxybutynin Chloride Er | 83 | $2,913 | $35 |
| Trospium Chloride Er | 11 | $2,485 | $226 |
| Nitrofurantoin Mono-Macro | 43 | $960 | $22 |
| Cephalexin | 107 | $667 | $6 |
| Nitrofurantoin | 20 | $663 | $33 |
| Alfuzosin Hcl Er | 14 | $649 | $46 |
| Allopurinol | 17 | $279 | $16 |
| Sulfamethoxazole-Trimethoprim | 55 | $203 | $4 |
| Hydrocodone-Acetaminophen | 23 | $122 | $5 |
| Amoxicillin-Clavulanate Potass | 12 | $116 | $10 |
| Acetaminophen-Codeine | 16 | $75 | $5 |
| Ciprofloxacin | 18 | $39 | $2 |
2020: 17 drugs
| Myrbetriq | 109 | $55,604 | $510 |
| Potassium Citrate Er | 40 | $7,841 | $196 |
| Estradiol | 45 | $7,468 | $166 |
| Estrace | 12 | $4,277 | $356 |
| Tamsulosin | 203 | $3,294 | $16 |
| Oxybutynin Chloride Er | 63 | $2,876 | $46 |
| Finasteride | 131 | $2,742 | $21 |
| Methenamine Hippurate | 16 | $1,713 | $107 |
| Nitrofurantoin | 26 | $893 | $34 |
| Nitrofurantoin Mono-Macro | 34 | $556 | $16 |
| Cephalexin | 71 | $416 | $6 |
| Doxazosin Mesylate | 16 | $351 | $22 |
| Allopurinol | 19 | $245 | $13 |
| Sulfamethoxazole-Trimethoprim | 35 | $178 | $5 |
| Levofloxacin | 12 | $163 | $14 |
| Ciprofloxacin | 28 | $122 | $4 |
| Acetaminophen-Codeine | 16 | $73 | $5 |
2019: 9 drugs
| Myrbetriq | 18 | $9,409 | $523 |
| Estradiol | 14 | $2,852 | $204 |
| Tamsulosin | 92 | $1,793 | $19 |
| Finasteride | 70 | $1,126 | $16 |
| Oxybutynin Chloride Er | 11 | $428 | $39 |
| Nitrofurantoin | 15 | $260 | $17 |
| Cephalexin | 18 | $159 | $9 |
| Ciprofloxacin | 16 | $103 | $6 |
| Sulfamethoxazole-Trimethoprim | 15 | $90 | $6 |
2018: 2 drugs
| Tamsulosin | 42 | $773 | $18 |
| Finasteride | 37 | $336 | $9 |
2017: 2 drugs
| Tamsulosin | 38 | $629 | $17 |
| Finasteride | 33 | $367 | $11 |
2016: 2 drugs
| Tamsulosin | 33 | $488 | $15 |
| Finasteride | 31 | $380 | $12 |
2015: 4 drugs
| Tamsulosin | 43 | $1,101 | $26 |
| Oxybutynin Chloride Er | 21 | $854 | $41 |
| Oxybutynin Chloride | 12 | $354 | $30 |
| Finasteride | 13 | $123 | $9 |
2014: 1 drug
| Oxycodone-Acetaminophen | 17 | $165 | $10 |
2013: 3 drugs
| Oxycodone-Acetaminophen | 50 | $306 | $6 |
| Ciprofloxacin | 24 | $104 | $4 |
| Sulfamethoxazole-Trimethoprim | 12 | $50 | $4 |
Money from drug and device companies
$386 in 2025
| 2025 | 3 | 3 | None | $386 |
| 2022 | 2 | 2 | None | $253 |
| 2021 | 2 | 2 | None | $244 |
| 2020 | 1 | 1 | None | $13 |
| 2019 | 1 | 2 | None | $3,013 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Spaceoar Vue System - 10ml | $159 | 1 payment
|
| Astellas Pharma US | Padcev | $115 | 1 payment
|
| Merck Sharp & Dohme | Keytruda | $112 | 1 payment
|
See all 3 published payments
| Astellas Pharma US | Meals · 2025-11-05 | Padcev | $115 |
| Merck Sharp & Dohme | Meals · 2025-11-03 | Keytruda | $112 |
| Boston Scientific | Meals · 2025-02-26 | Spaceoar Vue System - 10ml | $159 |
See earlier years (2022, 2021, 2020, 2019)
2022: $253
| PROCEPT BioRobotics | Aquabeam Robotic System | $153 | 1 payment
|
| Dornier MedTech America | Dornier Medtech | $100 | 1 payment
|
2021: $244
| Dornier MedTech America | Consumables & Accessories | $224 | 1 payment
|
| PROCEPT BioRobotics | Aquabeam Robotic System | $20 | 1 payment
|
2020: $13
| 180 Medical | Cure Hydro | $13 | 1 payment
|
2019: $3,013
| Intuitive Surgical | Da Vinci Surgical System | $3,013 | 2 payments
|
Professional record
- NPI
- 1114192119
- Licence
- CA A139890California A139890: Current · expires 2027-07-31
- Trained
- University of Michigan Medical School, 2008
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Urology (208800000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2008-04-30
- NPI last updated
- 2020-06-03
- NPI record certified
- 2020-06-03
This is when the NPI record was last certified, not a medical board exam.